Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer

American Journal of Clinical Pathology

Volumn 130, Issue 6, 2008, Pages 879-882

  Gomez Fernandez, Carmen ^a   Daneshbod, Yahya ^b   Nassiri, Mehdi ^a   Milikowski, Clara ^a   Alvarez, Consuelo ^a   Nadji, Mehrdad ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Daneshbod Pathology Laboratories   (Iran)

Author keywords

Breast cancer; Estrogen receptor; Immunohistochemistry; Metastatic breast carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; HORMONE;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; HORMONAL THERAPY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PHENOTYPE; RECEPTORS, ESTROGEN; TIME FACTORS;

EID: 58049217550     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPD1AO3YSYQYNW     Document Type: Article

References (14)

1. Allegra JC, Barlock A, Huff KK, et al. Changes in multiple or sequential estrogen receptor: determinations in breast cancer. Cancer. 1980;45:792-794.
2. Holdaway IM, Bowditch JV. Variation in receptor status between primary and metastatic breast cancer. Cancer. 1983;52:479-485.
3. Hull DF, Clark GM, Osborne CK, et al. Multiple estrogen receptor assays in human breast cancer. Cancer Res. 1982;43:413-416.
4. Kuukasjarvi T, Kononen J, Helin H, et al. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. J Clin Oncol. 1996;14:2584-2589.
5. Johnston SRD, Saccani-Jotti G, Smith E, et al. Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. Cancer Res. 1995;55:3331-3338.
6. Encarnacion CA, Ciocca DR, McGuire WL, et al. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen. Breast Cancer Res Treat. 1993;26:237-246.
7. Robertson JFR. Oestrogen receptor: a stable phenotype in breast cancer. Br J Cancer. 1996;73:5-12.
8. Osborne CK. Steroid receptors in breast cancer management. Breast Cancer Res Treat. 1998;51:227-238.
9. Sommer S, Fuqua SAW. Estrogen receptor and breast cancer. Semin Cancer Biol. 2001;11:339-352.
10. Dabbs DJ, Landreneau RJ, Liu Y, et al. Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma. Ann Thorac Surg. 2002;73:403-406.
11. McGuire WL, Chamness GC, Fuqua SAW. Estrogen receptor variants in clinical breast cancer. Mol Endocrinol. 1991;5:1571-1577.
12. Fuqua SAW, Wolf DM. Molecular aspects of estrogen receptor variants in breast cancer. Breast Cancer Res Treat. 1995;35:233-241.
13. Nadji M, Gomez-Fernandez C, Ganjei-Azar P, et al. Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers. Am J Clin Pathol. 2005;123:21-27.
14. Huang Z, Zhu W, Szekeres G, et al. Development of new rabbit monoclonal antibody to estrogen receptor. Appl Immunohistochem Mol Morphol. 2005;13:91-95.